Core Viewpoint - The company, Health Road (02587.HK), anticipates a profit of no less than RMB 6 million for the six months ending June 30, 2025, contrasting with a loss of approximately RMB 57.28 million for the same period in 2024, primarily due to changes in redeemable preference shares and listing expenses [1][2]. Financial Performance Summary - The expected revenue for the six months ending June 30, 2025, is projected to decrease by about 15% to 18% compared to the same period in 2024 [1]. - The gross profit for the six months ending June 30, 2025, is expected to decline by approximately 8% to 12% from the gross profit of RMB 183.66 million recorded for the six months ending June 30, 2024 [1]. Reasons for Revenue and Gross Profit Decline - The decrease in content service revenue is attributed to clients shifting to direct marketing strategies, reducing reliance on Real World Evidence (RWS) support services, and increased competition in the generic drug industry leading to budget cuts for RWS services [2]. - The decline in value-added medical service revenue is mainly due to the expiration of several sales agency agreements in 2025, ongoing negotiations for new agreements, and a proactive adjustment in service structure and classification [2]. - The reduction in digital marketing service revenue is linked to economic downturns prompting clients to cut advertising and marketing expenditures [2]. Company Overview - Health Road Co., Ltd. operates as a digital health service platform [3].
健康之路(02587.HK)：预计中期溢利人民币 600 万元